Julianne M O'Daniel1, Sara Ackerman2, Lauren R Desrosiers3, Shannon Rego4, Sara J Knight5, Lonna Mollison6, Grace Byfield6, Katherine P Anderson7, Maria I Danila8, Carol R Horowitz9, Galen Joseph10, Grace Lamoure11, Nangel M Lindberg12, Carmit K McMullen12, Kathleen F Mittendorf13, Michelle A Ramos9, Mimsie Robinson14, Catherine Sillari11, Ebony B Madden11. 1. Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: jodaniel@med.unc.edu. 2. Department of Social & Behavioral Sciences, School of Nursing, University of California San Francisco, San Francisco, CA. 3. Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX. 4. Institute for Human Genetics, University of California San Francisco, San Francisco, CA. 5. Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT. 6. Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. 7. Denver Health Ambulatory Care Services, Denver, CO. 8. Division of Clinical Immunology and Rheumatology, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL. 9. Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY. 10. Department of Humanities and Social Sciences, University of California San Francisco, San Francisco, CA. 11. National Human Genome Research Institute, National Institutes of Health, Bethesda, MD. 12. Center for Health Research Kaiser Permanente Northwest, Portland, OR. 13. Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN. 14. Bethel Gospel Assembly, New York, NY.
Abstract
PURPOSE: There is a critical need for genomic medicine research that reflects and benefits socioeconomically and ancestrally diverse populations. However, disparities in research populations persist, highlighting that traditional study designs and materials may be insufficient or inaccessible to all groups. New approaches can be gained through collaborations with patient/community stakeholders. Although some benefits of stakeholder engagement are recognized, routine incorporation into the design and implementation of genomics research has yet to be realized. METHODS: The National Institutes of Health-funded Clinical Sequencing Evidence-Generating Research (CSER) consortium required stakeholder engagement as a dedicated project component. Each CSER project planned and carried out stakeholder engagement activities with differing goals and expected outcomes. Examples were curated from each project to highlight engagement strategies and outcomes throughout the research lifecycle from development through dissemination. RESULTS: Projects tailored strategies to individual study needs, logistical constraints, and other challenges. Lessons learned include starting early with engagement efforts across project stakeholder groups and planned flexibility to enable adaptations throughout the project lifecycle. CONCLUSION: Each CSER project used more than 1 approach to engage with relevant stakeholders, resulting in numerous adaptations and tremendous value added throughout the full research lifecycle. Incorporation of community stakeholder insight improves the outcomes and relevance of genomic medicine research.
PURPOSE: There is a critical need for genomic medicine research that reflects and benefits socioeconomically and ancestrally diverse populations. However, disparities in research populations persist, highlighting that traditional study designs and materials may be insufficient or inaccessible to all groups. New approaches can be gained through collaborations with patient/community stakeholders. Although some benefits of stakeholder engagement are recognized, routine incorporation into the design and implementation of genomics research has yet to be realized. METHODS: The National Institutes of Health-funded Clinical Sequencing Evidence-Generating Research (CSER) consortium required stakeholder engagement as a dedicated project component. Each CSER project planned and carried out stakeholder engagement activities with differing goals and expected outcomes. Examples were curated from each project to highlight engagement strategies and outcomes throughout the research lifecycle from development through dissemination. RESULTS: Projects tailored strategies to individual study needs, logistical constraints, and other challenges. Lessons learned include starting early with engagement efforts across project stakeholder groups and planned flexibility to enable adaptations throughout the project lifecycle. CONCLUSION: Each CSER project used more than 1 approach to engage with relevant stakeholders, resulting in numerous adaptations and tremendous value added throughout the full research lifecycle. Incorporation of community stakeholder insight improves the outcomes and relevance of genomic medicine research.
Authors: Mary Fisher; Sarah E Brewer; John M Westfall; Matthew Simpson; Linda Zittleman; Sean T O'Leary; Douglas H Fernald; Andrea Nederveld; Donald E Nease Journal: J Am Board Fam Med Date: 2019 Sep-Oct Impact factor: 2.657
Authors: Yvonne A Joosten; Tiffany L Israel; Neely A Williams; Leslie R Boone; David G Schlundt; Charles P Mouton; Robert S Dittus; Gordon R Bernard; Consuelo H Wilkins Journal: Acad Med Date: 2015-12 Impact factor: 6.893
Authors: Claire Kendall; Michael Fitzgerald; Rachel Seoyeon Kang; Sabrina T Wong; Alan Katz; Martin Fortin; Emilie Dionne; Kerry Kuluski; Mary Ann O'Brien; Jenny Ploeg; Lois Crowe; Clare Liddy Journal: Res Involv Engagem Date: 2018-12-03
Authors: Jacqueline A Odgis; Katie M Gallagher; Sabrina A Suckiel; Katherine E Donohue; Michelle A Ramos; Nicole R Kelly; Gabrielle Bertier; Christina Blackburn; Kaitlyn Brown; Lena Fielding; Jessenia Lopez; Karla Lopez Aguiniga; Estefany Maria; Jessica E Rodriguez; Monisha Sebastin; Nehama Teitelman; Dana Watnick; Nicole M Yelton; Avinash Abhyankar; Noura S Abul-Husn; Aaron Baum; Laurie J Bauman; Jules C Beal; Toby Bloom; Charlotte Cunningham-Rundles; George A Diaz; Siobhan Dolan; Bart S Ferket; Vaidehi Jobanputra; Patricia Kovatch; Thomas V McDonald; Patricia E McGoldrick; Rosamond Rhodes; Michael L Rinke; Mimsie Robinson; Arye Rubinstein; Lisa H Shulman; Christian Stolte; Steven M Wolf; Elissa Yozawitz; Randi E Zinberg; John M Greally; Bruce D Gelb; Carol R Horowitz; Melissa P Wasserstein; Eimear E Kenny Journal: Trials Date: 2021-01-14 Impact factor: 2.279
Authors: Katrina A B Goddard; Frank A N Angelo; Sara L Ackerman; Jonathan S Berg; Barbara B Biesecker; Maria I Danila; Kelly M East; Lucia A Hindorff; Carol R Horowitz; Jessica Ezzell Hunter; Galen Joseph; Sara J Knight; Amy McGuire; Kristin R Muessig; Jeffrey Ou; Simon Outram; Elizabeth J Rahn; Michelle A Ramos; Christine Rini; Jill O Robinson; Hadley Stevens Smith; Margaret Waltz; Sandra Soo-Jin Lee Journal: J Clin Transl Sci Date: 2020-04-24
Authors: Catherine Chanfreau-Coffinier; Jane Peredo; Marcia M Russell; Elizabeth M Yano; Alison B Hamilton; Barbara Lerner; Dawn Provenzale; Sara J Knight; Corrine I Voils; Maren T Scheuner Journal: Genet Med Date: 2018-10-23 Impact factor: 8.822
Authors: Sabrina A Suckiel; Julianne M O'Daniel; Katherine E Donohue; Katie M Gallagher; Marian J Gilmore; Laura G Hendon; Galen Joseph; Billie R Lianoglou; Jennifer M Mathews; Mary E Norton; Jacqueline A Odgis; Alexis F Poss; Shannon Rego; Sarah Scollon; Tiffany Yip; Laura M Amendola Journal: J Pers Med Date: 2021-03-13